Market Overview

Rite Aid Falls On Technical Focus

Related RAD
Rite Aid Corporation Rallies On Increased Sales
Pharmacy Stocks Follow Walgreen Company's Lead Amid Earnings Release
Making Money With Charles Payne: 09/25/14 (Fox Business)

Shares of Rite Aid (NYSE: RAD) are down 4.4 percent amid investor speculation on common trends in its price graph.

Rite Aid has been testing the $7 price level since the drug retailer's positive Q4 earnings release in April, followed by a short-lived rally to all-time highs of $8.61. Following Rite Aid's rally from late April to early June, shares faced a modest sell-off, retracing back to the low $7 range.

It appears that traders have identified the $7 price level as a focus, being right above the mean 50 percent level year to date.

Posted-In: Movers Tech

 

Related Articles (RAD)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters